A method for preparing tetrazole methanesulfonic acid salts includes an acylation reaction using a novel 4-iodine-4H-chromene-2-carbothionic acid S-benzothiazole-2-yl ester. The method is advantageous that it can shorten a reaction time and improve safety as compared to conventional methods, and can prepare high-purity tetrazole methanesulfonic acid salts at a high yield rate without using a column chromatography method.
Drawings
Claims5
A compound of formula (II):
A method of preparing the compound of formula (II), which comprises the step of reacting the compound of formula (V) with the compound of formula (VI) in the presence of triphenylphosphine and a base:
21 Aug 2032Estimated · howhide20 years from earliest known nonprovisional domestic filing plus recorded patent term adjustment. Maintenance-fee lapses, terminal disclaimers and statutory extensions have not been checked. The continuity chain may be incomplete; this is not an enforceability determination.
Containing two hetero rings: linked by a carbon chain containing aromatic rings
Life of this patent
About 5 years 10 months of term left · ends 21 Aug 2032 (estimated)
Priority, Korea15 Jan 2010
Filed3 Feb 2014
Granted27 Jan 2015
Today12 Oct 2026
Term ends21 Aug 2032
Priority, Korea15 Jan 2010
Granted27 Jan 2015
Term ends21 Aug 2032
Priority claimedKR 10-2010-0003835
Application filedUS 14/171,318
PublishedUS 2014/0148602 A1
GrantedUS 8,940,908 B2
TodayWithin its term
Term endsEstimated
Description4,029 words
Summary438 words
#The present invention relates to a method for preparing tetrazole methanesulfonic acid salts and a novel compound used therein.
#Pharmaceutically acceptable salts of 4-oxo-4H-chromene-2-carboxylic acid [2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]-amine, as P-glycoprotein inhibitor, are useful as a multidrug resistance inhibitor. PCT Publication No. WO 2005/033097 discloses a preparation method thereof.
#According to the publication, as shown in Reaction Schemes 1 and 2, nitro-based compounds (1 and 3) undergo hydrogenation in a solvent such as methanol, ethanol, chloroform, dichloromethane, tetrahydrofuran, ethyl ether and hexane toluene, in the presence of a metal catalyst such as palladium, platinum and zinc to obtain amino compounds (2 and 4). The resulting compound is then subjected to an acylation using a condensing agent such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N,N-dicyclohexyldiimide, N,N-diisoprocarbodiimide and 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide methyl-p-toluenesulfonate, in the presence of a catalyst such as 4-(dimethylamino)pyridine in a solvent such as dichloromethane, chloroform, N,N-dimethylformamide, tetrahydrofuran, and 1,4-dioxane, to obtain a tetrazole compound (5) as a final product.
Detailed description3,591 words
#Hereinafter, the present invention is described in detail.
#The preparation method according to the present invention employs an acylation process using a novel compound, 4-oxo-4H-chromene-2-carbothionic acid S-benzothiazol-2-yl ester, instead of using a condensing agent as in conventional methods, to obtain tetrazole methanesulfonic acid salts with a high purity at a high yield, without an additional purification process such as a column chromatography.
#As shown in Reaction Scheme 3 below, the method for preparing tetrazole methanesulfonic acid salts according to the present invention comprises: (Step 1) acylating the compound of formula (II) with the compound of formula (III) to obtain the compound of formula (IV); and (Step 2) adding methanesulfonic acid to the compound of formula (IV) obtained in the above step.